Cite

    Ming, S. W. Y., Haughney, J., Ryan, D., Small, I., Lavorini, F., Gruffydd-Jones, K., Papi, A., Singh, D., Halpin, D., Hurst, J., Patel, S., Ochel, M., & Price, D. (n.d.). p274 Comparison of the initiation of copd treatment with licensed fdc ics/laba treatments in terms of disease control and cost effectiveness. Thorax, 72, A232. http://access.bl.uk/ark:/81055/vdc_100137791453.0x000027